Stock listing

NASDAQ:ZJYL Jin Medical International Ltd. Stock

Home listing (NASDAQ) of Jin Medical International Ltd.

Follow Jin Medical International Ltd. into a list and get an email when it puts out news.

Share price · NASDAQ:ZJYL

$3.38 USD +0.02 (+0.6%)

Close on Nov 20, 2026

Past year -35.2% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$3.30 – $3.43 USDNov 20, 2026
Volume
32,431 sharesNov 20, 2026
Market cap
$518.6M USDAt the close on Nov 20, 2026 · price × 153.4M shares outstanding
52-week range
$1.53 – $5.60 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$310,167 USDMedian day 20,900 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Jin Medical International Ltd. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:ZJYL · Home$3.38 USD+0.02 (+0.6%)32,431$3.35$3.429$3.30$3.36Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:ZJYL · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$3.38+0.02+0.6%$3.35$3.429$3.3032,431
$3.36-0.015-0.4%$3.293$3.44$3.2933,926
$3.375-0.255-7.0%$3.616$3.62$3.21424,797
$3.63+0.13+3.7%$3.50$3.77$3.4334,249
$3.50-0.37-9.6%$3.601$3.601$3.41518,789
$3.87-1.04-21.2%$4.68$4.68$3.01153,588
$4.91+0.70+16.6%$4.27$4.95$4.215228,826
$4.21+0.26+6.6%$3.84$4.26$3.78131,128
$3.95+0.59+17.6%$3.36$3.95$3.3698,848
$3.36+0.14+4.3%$3.08$3.36$2.9365,600
$3.22+0.13+4.2%$2.99$3.22$2.9847,200
$3.09+0.37+13.6%$2.80$3.09$2.50283,500
$2.72+0.52+23.6%$2.33$2.72$2.25126,700
$2.20-0.15-6.4%$2.33$2.42$2.07489,300
$2.35+0.49+26.3%$1.90$2.83$1.833,686,400
$1.86-0.04-2.1%$1.91$1.91$1.861,600
$1.90-0.093-4.7%$1.97$2.094$1.8622,200
$1.993+0.053+2.7%$1.954$2.055$1.9031,500
$1.94-0.11-5.4%$1.931$2.038$1.9312,400
$2.05+0.03+1.5%$1.92$2.05$1.924,200
$2.02-0.071-3.4%$1.947$2.09$1.923,400
$2.091+0.061+3.0%$1.935$2.15$1.8571,700
$2.03-0.08-3.8%$2.07$2.16$2.003,700
$2.11+0.03+1.4%$2.111$2.14$2.0179,900
$2.08-0.075-3.5%$2.18$2.24$2.0817,300
$2.155+0.135+6.7%$2.04$2.155$1.9924,000
$2.02-0.04-1.9%$2.00$2.10$1.9915,600
$2.06-0.14-6.4%$2.10$2.15$2.0258,100
$2.20+0.14+6.8%$2.06$2.22$2.0025,100
$2.06-0.06-2.8%$2.05$2.112$1.9712,100
$2.120.000.0%$2.085$2.234$2.00513,200
$2.12+0.13+6.5%$1.922$2.12$1.92222,200
$1.99+0.01+0.5%$1.96$1.99$1.9115,000
$1.98+0.04+2.1%$1.894$2.025$1.8946,000
$1.94-0.06-3.0%$1.97$1.99$1.943,700
$2.00+0.09+4.7%$1.98$2.00$1.9210,100
$1.91+0.03+1.6%$1.955$2.05$1.9112,200
$1.88-0.07-3.6%$1.86$1.93$1.867,400
$1.95+0.04+2.1%$2.00$2.00$1.8514,000
$1.91-0.09-4.5%$1.94$2.01$1.9033,100
$2.00-0.05-2.4%$1.99$2.079$1.91367,500
$2.05-0.03-1.4%$2.07$2.18$2.0219,100
$2.08+0.01+0.5%$2.05$2.11$1.92512,900
$2.07+0.08+4.0%$2.02$2.07$1.949,200
$1.99+0.01+0.5%$2.06$2.06$1.8938,000
$1.98+0.01+0.5%$2.06$2.08$1.8839,300
$1.97-0.02-1.0%$1.985$2.013$1.8713,800
$1.99+0.02+1.0%$1.97$1.99$1.9211,700
$1.97-0.10-4.8%$2.09$2.09$1.8516,400
$2.07+0.01+0.5%$2.05$2.13$2.0118,700
$2.06-0.19-8.4%$2.20$2.229$2.02350,500
$2.25+0.23+11.4%$1.97$2.31$1.84837,700
$2.02-0.06-2.9%$2.07$2.09$2.001,176,600
$2.08-0.07-3.3%$2.14$2.276$2.0727,800
$2.15+0.05+2.4%$2.15$2.27$2.1522,800
$2.10-0.10-4.5%$2.19$2.20$2.1027,500
$2.20-0.12-5.2%$2.32$2.553$2.2013,400
$2.32-0.02-0.9%$2.34$2.415$2.3220,900
$2.34-0.01-0.4%$2.36$2.52$2.3417,400
$2.35-0.44-15.8%$2.78$2.80$2.3557,800
$2.79+0.02+0.7%$2.81$2.975$2.7131,600
$2.77-0.27-8.9%$3.02$3.28$2.7087,900
$3.040.000.0%$3.09$3.28$3.0255,700
$3.04+0.01+0.3%$3.10$3.183$3.0440,000
$3.03-0.05-1.6%$3.08$3.15$2.9751,100

Splits

2 splits since 2024 · NASDAQ:ZJYL · every price before a split is adjusted for it

DayRatioWhat
1-for-20Consolidation
20-for-1Split
Ticker
NASDAQ:ZJYL
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Jin Medical International Ltd. news

Jin Medical International Ltd. on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
10 in the last 12 months · 31 in all · newest Nov 3, 2026 · oldest 2023

Where Jin Medical International Ltd. is listed

ListingExchangeCountryCurrency
NASDAQ:ZJYL · Home listing · This pageNASDAQUnited StatesUSD
BOATS:ZJYLBOATSUnited StatesUSD

Valuation

P/E 435× against a median of 25.9×: the highest of 7 Medical devices & supplies companies shown. Statements: Year to Sep 30, 2025 · balance Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$509.1M USD
P/E
435×
EV/sales
24.6×
EV/EBITDA
598×
Price/book
17.1×
Gross margin
29.2%
Operating margin
2.9%
Net margin
5.8%
Debt to equity
0.7×
Beta vs S&P 500
0.92

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Jin Medical International Ltd. · NASDAQ:ZJYLUS$518.6MUS$509.1M435×24.6×598×17.1×5.8%0.7×0.92
Visco Vision Inc. · TWSE:6782US$541.8MUS$572.3M15.1×3.8×9.3×3.7×23.5%0.4×n/a
Ningbo David Medical Device Co., Ltd. Class A · SZSE:300314US$529.5MUS$435.6M38.3×4.7×n/a2.7×15.0%0.0×n/a
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H · HKEX:2291US$525.3MUS$332.3M14.6×4.2×7.2×1.8×45.4%0.0×n/a
Zhejiang Gongdong Medical Technology Co. Ltd. Class A · SSE:605369US$512.0MUS$407.8M47.7×2.3×n/a2.0×6.0%0.0×n/a
Ion Beam Applications SA · EURONEXT:IBABUS$511.8MUS$593.9M36.6×0.9×12.9×3.9×2.1%1.0×n/a
Contec Medical Systems Co. Ltd. Class A · SZSE:300869US$506.6MUS$348.7Mn/a4.9×n/a2.0×−19.1%0.5×n/a
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class A · SSE:688236US$494.6MUS$175.5M12.1×1.1×3.5×1.1×26.1%0.0×n/a
Avita Medical, Inc. · NASDAQ:RCELUS$490.8MUS$525.8Mn/a6.2×n/an/a−42.6%n/a1.37
Chimin Health Management Co., Ltd. Class A · SSE:603222US$487.9MUS$484.6Mn/a5.0×n/a3.1×−39.2%0.2×n/a
Anteris Technologies Global Corp. · NASDAQ:AVRUS$486.5MUS$269.6Mn/a116×n/a2.1×n/a0.0×1.43
Median of the othersUS$509.2MUS$421.7M25.9×4.5×8.3×2.1×6.0%0.0×1.40

Events

QuarterResultsShare move
Q1 2026Jan 23, 2026 · After close+5.2%
Q3 2025Aug 20, 2025−5.5%
Q1 2025Jan 24, 2025−10.1%
Q1 2023Mar 21, 2023
Q4 2022Dec 20, 2022
Q4 2021Dec 10, 2021
Quarter to Jun 30, 2021Sep 24, 2021

Open Events

IPO

Priced at US$8.00 a share on Mar 27, 2023.

Price
US$8.00 a share
Shares offered
1,000,000 ordinary shares
Offering size
US$8 million
Listing
ZJYL on the Nasdaq Capital Market
Shares delivered
On or about Mar 30, 2023

Steps

StepWhen
Draft sent to the SEC in confidenceDec 28, 2020
Filed publiclySep 24, 2021
Amended 13 timesNewest Mar 21, 2023
Shares registered with an exchangeMar 23, 2023
Declared effective by the SECMar 27, 2023
Final prospectus, with the priceMar 29, 2023

Filings

FilingFiled
424B4 · ProspectusMar 29, 2023
CERT · Exchange's certificate of listingMar 28, 2023
EFFECT · Notice that a registration is effectiveMar 27, 2023
8-A12B · Registration of shares for listing on an exchangeMar 23, 2023
CORRESP · Letter to the SECMar 23, 2023
CORRESP · Letter to the SECMar 23, 2023
F-1/A · Registration statement, amendedMar 21, 2023
CORRESP · Letter to the SECMar 7, 2023
F-1/A · Registration statement, amendedMar 7, 2023
UPLOAD · Letter from the SECMar 2, 2023
All 44 filings
FilingFiled
F-1/A · Registration statement, amendedFeb 24, 2023
F-1/A · Registration statement, amendedDec 20, 2022
CORRESP · Letter to the SECDec 1, 2022
F-1/A · Registration statement, amendedDec 1, 2022
UPLOAD · Letter from the SECNov 21, 2022
F-1/A · Registration statement, amendedNov 17, 2022
CORRESP · Letter to the SECSep 13, 2022
F-1/A · Registration statement, amendedSep 13, 2022
UPLOAD · Letter from the SECSep 8, 2022
CORRESP · Letter to the SECAug 31, 2022
F-1/A · Registration statement, amendedAug 31, 2022
UPLOAD · Letter from the SECAug 19, 2022
CORRESP · Letter to the SECAug 10, 2022
F-1/A · Registration statement, amendedAug 10, 2022
UPLOAD · Letter from the SECJul 26, 2022
CORRESP · Letter to the SECJul 15, 2022
F-1/A · Registration statement, amendedJul 15, 2022
UPLOAD · Letter from the SECApr 28, 2022
CORRESP · Letter to the SECApr 1, 2022
F-1/A · Registration statement, amendedApr 1, 2022
UPLOAD · Letter from the SECMar 1, 2022
F-1/A · Registration statement, amendedFeb 4, 2022
CORRESP · Letter to the SECFeb 4, 2022
UPLOAD · Letter from the SECDec 20, 2021
CORRESP · Letter to the SECDec 10, 2021
F-1/A · Registration statement, amendedDec 10, 2021
UPLOAD · Letter from the SECNov 16, 2021
F-1 · Registration statementSep 24, 2021
CORRESP · Letter to the SECSep 24, 2021
UPLOAD · Letter from the SECJul 16, 2021
DRSLTR · Letter to the SEC with a draftJun 30, 2021
DRS/A · Draft registration statement, amendedJun 30, 2021
UPLOAD · Letter from the SECJan 22, 2021
DRS · Draft registration statementDec 28, 2020

Open IPO · From the cover of the final prospectus (424B4) filed Mar 29, 2023

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue20.7M23.5M19.8M19.2M20.8M16.2M20.4M20.9M
Cost of revenue14.6M14.0M13.0M13.0M14.4M10.7M12.9M13.3M
Gross profit6.04M9.50M6.78M6.20M6.36M5.50M7.51M7.66M
Research and development1.56M1.50M1.54M1.89M1.57M1.26M1.13M1.20M
Selling, general and administrative2.53M3.26M2.37M1.77M1.67M1.50M1.60M1.72M
Operating income608.2K3.64M2.87M2.13M2.63M2.35M4.40M4.23M
Depreciation and amortization243.4K237.8K225.9K362.6K346.6K324.9K344.0K368.3K
EBITDA851.6K3.88M3.09M2.49M2.98M2.68M4.75M4.60M
Interest expense9.49K112.4K22.8K
Income before tax1.60M4.18M3.22M2.74M2.88M2.35M4.13M4.30M
Income tax214.6K763.9K343.7K36.1K248.6K147.2K479.6K616.9K
Net income1.19M3.68M2.88M2.71M2.63M2.21M3.65M3.68M
Earnings per share, basic0.010.020.020.020.020.110.180.18
Earnings per share, diluted0.010.020.020.020.02

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash and equivalents7.46M8.14M6.93M4.79M3.67M1.66M1.94M853.3K
Short-term investments22.2M18.6M9.77M2.28M2.05M1.18M1.40M1.60M
Receivables5.81M5.91M3.28M3.83M5.98M7.86M8.63M6.34M
Inventory4.92M5.17M5.05M6.72M7.04M7.25M5.74M6.06M
Current assets44.1M42.8M31.1M18.9M19.4M18.2M17.7M15.6M
Property, plant and equipment7.90M1.46M1.48M1.63M2.11M2.31M2.38M
Total assets53.4M45.8M32.9M20.9M21.9M20.8M20.4M18.7M
Accounts payable3.26M3.01M3.39M4.11M5.35M5.43M4.76M7.75M
Current liabilities23.8M17.2M8.92M5.70M7.87M10.0M9.66M9.68M
Total debt18.9M11.6M2.65M2.87M712.5K
Total liabilities23.8M17.2M8.92M5.70M7.87M10.0M9.66M9.68M
Shareholders' equity29.6M28.8M24.0M15.2M14.0M10.8M10.7M9.00M
Shares outstanding156.5M155.9M155.9M135.0M156.5M20.0M20.0M20.0M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations2.90M-1.21M3.11M1.58M5.84M2.50M-1.33M-2.39M
Capital spending-6.63M-144.9K-113.9K-40.2K-42.9K-142.3K-73.3K-187.7K
Free cash flow-3.73M-1.35M2.99M1.54M5.80M2.36M-1.40M-2.58M
Cash from investing-10.8M-9.51M-7.73M-120.9K-1.07M-1.96M126.9K1.96M
Cash from financing7.35M11.7M6.91M121.9K-2.87M-343.9K2.36M-3.19M
Change in cash-674.5K1.21M2.14M1.12M2.01M-278.4K1.09M-3.59M

Open Financials

Filings

FilingDateTypeFiled with
F-3ASRNov 20, 2026Other filingsSEC
6-K · Report of a foreign issuerOct 30, 2026Current reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedSep 25, 2026Big-stake noticeSEC
6-K · Report of a foreign issuerSep 24, 2026Current reportSEC
6-K · Report of a foreign issuerSep 8, 2026Current reportSEC
SCHEDULE 13D · Big-stake noticeAug 21, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeAug 18, 2026Big-stake noticeSEC
6-K · Report of a foreign issuerAug 4, 2026Current reportSEC
6-K · Report of a foreign issuerJul 20, 2026Current reportSEC
3 · Initial statement of ownershipJul 16, 2026Insider tradeSEC
All 116 filings
FilingDateTypeFiled with
6-K · Report of a foreign issuerJul 15, 2026Current reportSEC
6-K/A · Report of a foreign issuer, amendedJun 30, 2026Current reportSEC
6-K · Report of a foreign issuerJun 29, 2026Current reportSEC
6-K · Report of a foreign issuerJun 4, 2026Current reportSEC
3 · Initial statement of ownershipMay 6, 2026Insider tradeSEC
3 · Initial statement of ownershipApr 27, 2026Insider tradeSEC
3 · Initial statement of ownershipApr 24, 2026Insider tradeSEC
3 · Initial statement of ownershipApr 24, 2026Insider tradeSEC
3 · Initial statement of ownershipApr 24, 2026Insider tradeSEC
6-K · Report of a foreign issuerApr 7, 2026Current reportSEC
6-K · Report of a foreign issuerMar 17, 2026Current reportSEC
20-F · Annual reportFeb 9, 2026Annual reportSEC
6-K · Report of a foreign issuerFeb 9, 2026Current reportSEC
6-K · Report of a foreign issuerFeb 4, 2026Current reportSEC
NT 20-FJan 30, 2026Explanation requestSEC
6-K · Report of a foreign issuerJan 28, 2026Current reportSEC
6-K · Report of a foreign issuerJan 22, 2026Current reportSEC
6-K · Report of a foreign issuerJan 21, 2026Current reportSEC
6-K · Report of a foreign issuerJan 8, 2026Current reportSEC
EFFECT · Notice that a registration is effectiveSep 10, 2025Other filingsSEC
CORRESP · Letter to the SECSep 5, 2025Other filingsSEC
F-3/A · Registration statement, amendedSep 3, 2025Offer documentSEC
6-K · Report of a foreign issuerAug 20, 2025Current reportSEC
144 · Notice of proposed saleJul 17, 2025Other filingsSEC
6-K · Report of a foreign issuerJul 16, 2025Current reportSEC
UPLOAD · Letter from the SECJul 1, 2025Other filingsSEC
F-3 · Registration statementJun 25, 2025Offer documentSEC
6-K · Report of a foreign issuerJun 24, 2025Current reportSEC
6-K · Report of a foreign issuerJun 17, 2025Current reportSEC
6-K · Report of a foreign issuerMay 6, 2025Current reportSEC
6-K · Report of a foreign issuerApr 25, 2025Current reportSEC
UPLOAD · Letter from the SECMar 25, 2025Other filingsSEC
CORRESP · Letter to the SECMar 20, 2025Other filingsSEC
20-F/A · Annual report, amendedMar 20, 2025Annual reportSEC
UPLOAD · Letter from the SECMar 6, 2025Other filingsSEC
20-F · Annual reportJan 24, 2025Annual reportSEC
6-K · Report of a foreign issuerOct 11, 2024Current reportSEC
6-K · Report of a foreign issuerJul 26, 2024Current reportSEC
6-K · Report of a foreign issuerMay 14, 2024Current reportSEC
20-F · Annual reportApr 26, 2024Annual reportSEC
6-K · Report of a foreign issuerApr 12, 2024Current reportSEC
6-K · Report of a foreign issuerMar 29, 2024Current reportSEC
6-K · Report of a foreign issuerMar 6, 2024Current reportSEC
6-K · Report of a foreign issuerMar 1, 2024Current reportSEC
6-K · Report of a foreign issuerFeb 23, 2024Current reportSEC
SC 13G · Big-stake noticeFeb 14, 2024Big-stake noticeSEC
6-K · Report of a foreign issuerFeb 5, 2024Current reportSEC
6-K · Report of a foreign issuerFeb 1, 2024Current reportSEC
6-K · Report of a foreign issuerFeb 1, 2024Current reportSEC
NT 20-FJan 31, 2024Explanation requestSEC
6-K · Report of a foreign issuerJan 11, 2024Current reportSEC
6-K · Report of a foreign issuerDec 27, 2023Current reportSEC
6-K · Report of a foreign issuerDec 26, 2023Current reportSEC
6-K · Report of a foreign issuerDec 20, 2023Current reportSEC
6-K · Report of a foreign issuerDec 14, 2023Current reportSEC
6-K · Report of a foreign issuerDec 13, 2023Current reportSEC
6-K · Report of a foreign issuerDec 12, 2023Current reportSEC
6-K · Report of a foreign issuerDec 11, 2023Current reportSEC
144 · Notice of proposed saleOct 24, 2023Other filingsSEC
6-K · Report of a foreign issuerAug 23, 2023Current reportSEC
6-K · Report of a foreign issuerApr 6, 2023Current reportSEC
6-K · Report of a foreign issuerMar 30, 2023Current reportSEC
424B4 · ProspectusMar 29, 2023Offer documentSEC
CERT · Exchange's certificate of listingMar 28, 2023Other filingsSEC
EFFECT · Notice that a registration is effectiveMar 28, 2023Other filingsSEC
8-A12B · Registration of shares for listing on an exchangeMar 23, 2023Other filingsSEC
CORRESP · Letter to the SECMar 23, 2023Other filingsSEC
CORRESP · Letter to the SECMar 23, 2023Other filingsSEC
F-1/A · Registration statement, amendedMar 21, 2023Offer documentSEC
CORRESP · Letter to the SECMar 7, 2023Other filingsSEC
F-1/A · Registration statement, amendedMar 7, 2023Offer documentSEC
UPLOAD · Letter from the SECMar 2, 2023Other filingsSEC
F-1/A · Registration statement, amendedFeb 24, 2023Offer documentSEC
F-1/A · Registration statement, amendedDec 20, 2022Offer documentSEC
CORRESP · Letter to the SECDec 1, 2022Other filingsSEC
F-1/A · Registration statement, amendedDec 1, 2022Offer documentSEC
UPLOAD · Letter from the SECNov 21, 2022Other filingsSEC
F-1/A · Registration statement, amendedNov 17, 2022Offer documentSEC
CORRESP · Letter to the SECSep 13, 2022Other filingsSEC
F-1/A · Registration statement, amendedSep 13, 2022Offer documentSEC
UPLOAD · Letter from the SECSep 8, 2022Other filingsSEC
CORRESP · Letter to the SECAug 31, 2022Other filingsSEC
F-1/A · Registration statement, amendedAug 31, 2022Offer documentSEC
UPLOAD · Letter from the SECAug 19, 2022Other filingsSEC
CORRESP · Letter to the SECAug 10, 2022Other filingsSEC
F-1/A · Registration statement, amendedAug 10, 2022Offer documentSEC
UPLOAD · Letter from the SECJul 26, 2022Other filingsSEC
CORRESP · Letter to the SECJul 15, 2022Other filingsSEC
F-1/A · Registration statement, amendedJul 15, 2022Offer documentSEC
UPLOAD · Letter from the SECApr 28, 2022Other filingsSEC
CORRESP · Letter to the SECApr 1, 2022Other filingsSEC
F-1/A · Registration statement, amendedApr 1, 2022Offer documentSEC
UPLOAD · Letter from the SECMar 1, 2022Other filingsSEC
F-1/A · Registration statement, amendedFeb 4, 2022Offer documentSEC
CORRESP · Letter to the SECFeb 4, 2022Other filingsSEC
UPLOAD · Letter from the SECDec 20, 2021Other filingsSEC
CORRESP · Letter to the SECDec 10, 2021Other filingsSEC
F-1/A · Registration statement, amendedDec 10, 2021Offer documentSEC
UPLOAD · Letter from the SECNov 16, 2021Other filingsSEC
F-1 · Registration statementSep 24, 2021Offer documentSEC
CORRESP · Letter to the SECSep 24, 2021Other filingsSEC
UPLOAD · Letter from the SECJul 16, 2021Other filingsSEC
DRSLTR · Letter to the SEC with a draftJun 30, 2021Other filingsSEC
DRS/A · Draft registration statement, amendedJun 30, 2021Offer documentSEC
UPLOAD · Letter from the SECJan 22, 2021Other filingsSEC
DRS · Draft registration statementDec 23, 2020Offer documentSEC

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Jin Medical International Ltd.’s releases

Common shares
153,425,476
Fully diluted
153,425,476

Fully diluted

LineShares
Common shares153,425,476

Share count over time

CountShares
Nov 22, 2026153,425,476

Open Cap table

Shareholders

Institutions

HolderSharesValueAs of
Caitong International Asset Management Co., Ltd15US$29Sep 30, 2026
JPMorgan7US$13Sep 30, 2026

Funds

HolderSharesValueAs of
Fidelity Nasdaq Composite Index Fund5,327US$11,932May 31, 2026

Big stakes

StakeStakeSharesDateFiling
NOVASTRALIST HORIZON LTD.10.46%7.7MAug 18, 2026Schedule 13G
Erqi Wang3.35%5.31MSep 24, 2026Schedule 13D

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
James Jiayuan Tong
Other companies: Horizon Space Acquisition II Corp. (Director · Nov 12, 2024 – Nov 12, 2024 · Past); Xynomic Pharmaceuticals Holdings Inc (CEO and CFO, Director · Jun 19, 2017 – Jun 19, 2017 · Past); Tianyin Pharmaceutical Co Inc (CFO & Director & CBDO, Director · Apr 1, 2010 – May 28, 2014 · Past)
Director · Since at least Mar 18, 2026
Erqi WangChief Executive Officer, Director · Since at least Mar 18, 2026
Ning XueDirector · Since at least Jul 16, 2026
Oliver St Clair Franklin JrDirector · Since at least Mar 18, 2026
Yanru GuoDirector · Since at least Mar 18, 2026
Ziqiang WangChief Financial Officer, Director · Since at least Mar 18, 2026

Open People

Log in to ask 6ix AI your own questions about Jin Medical International Ltd.